Pathogenesis of interstitial lung disease in children and adults

Pediatric, Allergy, Immunology, and Pulmonology

Volumn 23, Issue 1, 2010, Pages 9-14

  Glasser, Stephan W ^a   Hardie, William D ^b   Hagood, James S ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BOMBESIN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; SURFACTANT; SURFACTANT PROTEIN B;

ADULT DISEASE; ARTICLE; CHILDHOOD DISEASE; DESQUAMATIVE INTERSTITIAL PNEUMONIA; DIFFUSE IDIOPATHIC PULMONARY NEUROENDOCRINE CELL HYPERPLASIA; EPITHELIAL MESENCHYMAL TRANSITION; GENE MUTATION; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS PROTEINOSIS; LUNG DEVELOPMENT; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEURENDOCRINE CELL HYPERPLASIA; NONHUMAN; NONSPECIFIC INTERSTITIAL PNEUMONIA; OXYGEN THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 78049398776     PISSN: 2151321X     EISSN: 21513228     Source Type: Journal    
DOI: 10.1089/ped.2010.0004     Document Type: Article

References (51)

1. Fan LL, Langston C, Pediatric interstitial lung disease: children are not small adults, Am J Respir Crit Care Med 2002; 165: 1466-1467.
2. Simmons RA, Developmental origins of adult disease, Pediatr Clin North Am 2009; 56: 449-466.
3. Martinez FD, The origins of asthma and chronic obstructive pulmonary disease in early life, Proc Am Thorac Soc 2009; 6: 272-277.
4. Hardie WD, Glasser SW, Hagood JS, Emerging concepts in the pathogenesis of lung fi brosis, Am J Pathol 2009; 175: 3-16.
5. Katzenstein AL, Myers JL, Idiopathic pulmonary fi brosis: clinical relevance of pathologic classifi cation, Am J Respir Crit Care Med 1998; 157: 1301-1315.
6. Selman M, King TE, Pardo A, Idiopathic pulmonary fi brosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy, Ann Intern Med 2001; 134: 136-151.
7. Selman M, Pardo A, Idiopathic pulmonary fi brosis: misunderstandings between epithelial cells and fi broblasts? Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 165-172.
8. Thannickal VJ, Idiopathic interstitial pneumonia: a clinicopathological perspective, Semin Respir Crit Care Med 2006; 27: 569-573.
9. Adamson IYR, Hedgecock C, Bowden DH, Epithelial cell-fi broblast interactions in lung injury and repair, Amer J Path 1990; 137: 385-392.
10. Clark RA, The commonality of cutaneous wound repair and lung injury, Chest 1991; 99: 57S-60S
11. Demayo F, Minoo P, Plopper CG, Schuger L, Shannon J, Torday JS, Mesenchymal-epithelial interactions in lung development and repair: are modeling and remodeling the same process? Am J Physiol Lung Cell Mol Physiol 2002; 283: L510-L517
12. Torday JS, Rehan VK, The evolutionary continuum from lung development to homeostasis and repair, Am J Physiol Lung Cell Mol Physiol 2007; 292: L608-L611
13. Shannon JM, Nielsen LD, Gebb SA, Randell SH, Mesenchyme specifi es epithelial differentiation in reciprocal recombinants of embryonic lung and trachea, Dev Dyn 1998; 212: 482-494.
14. Selman M, Pardo A, Kaminski N, Idiopathic pulmonary fi brosis: aberrant recapitulation of developmental programs? PLoS Med 2008; 5: e62
15. Tuder RM, Yun JH, Bhunia A, Fijalkowska I, Hypoxia and chronic lung disease, J Mol Med 2007; 85: 1317-1324.
16. Selman M, Pardo A, Role of epithelial cells in idiopathic pulmonary fi brosis: from innocent targets to serial killers, Proc Am Thorac Soc 2006; 3: 364-372.
17. Nogee LM. Genetic basis of children's interstitial lung disease. Pediatric Allergy, Immunology, and Pulmonology 2010; 23:15-24.
18. Nogee LM, de Mello DE, Dehner LP, Colten HR, Brief report: defi ciency of pulmonary surfactant protein B in congenital alveolar proteinosis, N Engl J Med 1993; 328: 406-410.
19. Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, deMello DE, Colten HR, A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994; 93: 1860-1863.
20. Hamvas A, Cole FS, deMello DE, Moxley M, Whitsett JA, Colten HR, Nogee LM, Surfactant protein B defi ciency: antenatal diagnosis and prospective treatment with surfactant replacement, J Pediatr 1994; 125: 356-361.
21. Ballard PL, Nogee LM, Beers MF, Ballard RA, Planer BC, Polk L, deMello DE, Moxley MA, Longmore WJ, Partial defi ciency of surfactant protein B in an infant with chronic lung disease, Pediatrics 1995; 96: 1046-1052.
22. Thomas AQ, Lane K, Phillips J, III, Prince M, Markin C, Speer M, Schwartz DA, Gaddipati R, Marney A, Johnson J, Roberts R, Haines J, Stahlman M, Loyd JE, Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecifi c interstitial pneumonitis in one kindred, Am J Respir Crit Care Med 2002; 165: 1322-1328.
23. Wert SE, Whitsett JA, Nogee LM, Genetic disorders of surfactant dysfunction, Pediatr Dev Pathol 2009; 12: 253-274.
24. Lawson WE, Grant SW, Ambrosini V, Womble K, Dawson E, Lane K, Markin C, Renzoni E, Lympany P, Thomas A, Roldan J, Scott T, Blackwell T, Phillips J, Loyd J, du Bois RM, Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF, Thorax 2004; 59: 977-980.
25. Markart P, Ruppert C, Wygrecka M, Schmidt R, Korfei M, Harbach H, Theruvath I, Pison U, Seeger W, Guenther A, Witt H, Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias, Eur Respir J 2007; 29: 134-137.
26. Kaarteenaho-Wiik R, Mertaniemi P, Sajanti E, Soini Y, Paakko P, Tenascin is increased in epithelial lining fl uid in fi brotic lung disorders, Lung 1998; 176: 371-380.
27. Korfei M, Ruppert C, Mahavadi P, Henneke I, Markart P, Koch M, Lang G, Fink L, Bohle RM, Seeger W, Weaver TE, Guenther A, Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fi brosis, Am J Respir Crit Care Med 2008; 178: 838-846.
28. Lawson WE, Crossno PF, Polosukhin VV, Roldan J, Cheng D-S, Lane KB, Blackwell TR, Xu C, Markin C, Ware LB, Miller GG, Loyd JE, Blackwell TS, Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection, Am J Physiol Lung Cell Mol Physiol 2008; 294: L1119-L1126
29. Bridges JP, Wert SE, Nogee LM, Weaver TE, Expression of a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice, J Biol Chem 2003; 278: 52739-52746.
30. Glasser SW, Detmer EA, Ikegami M, Na CL, Stahlman MT, Whitsett JA, Pneumonitis and emphysema in sp-C gene targeted mice, J Biol Chem 2003; 278: 14291-14298.
31. Lawson WE, Polosukhin VV, Stathopoulos GT, Zoia O, Han W, Lane KB, Li B, Donnelly EF, Holburn GE, Lewis KG, Collins RD, Hull WM, Glasser SW, Whitsett JA, Blackwell TS, Increased and prolonged pulmonary fi brosis in surfactant protein C-defi cient mice following intratracheal bleomycin, Am J Pathol 2005; 167: 1267-1277.
32. Glasser SW, Senft AP, Whitsett JA, Maxfi eld MD, Ross GF, Richardson TR, Prows DR, Xu Y, Korfhagen TR, Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-defi cient mice, J Immunol 2008; 181: 621-628.
33. Glasser SW, Witt TL, Senft AP, Baatz JE, Folger D, Maxfi eld MD, Akinbi HT, Newton DA, Prows DR, Korfhagen TR, Surfactant protein C-defi cient mice are susceptible to respiratory syncytial virus infection, Am J Physiol Lung Cell Mol Physiol 2009; 297: L64-L72
34. Bullard JE, Wert SE, Whitsett JA, Dean M, Nogee LM, ABCA3 mutations associated with pediatric interstitial lung disease, Am J Respir Crit Care Med 2005; 172: 1026-1031.
35. Young LR, Nogee LM, Barnett B, Panos RJ, Colby TV, Deutsch GH, Usual interstitial pneumonia in an adolescent with ABCA3 mutations, Chest 2008; 134: 192-195.
36. Matsumura Y, Ban N, Inagaki N, Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in ABCA3 mutants associated with nonfatal pediatric interstitial lung disease. Am J Physiol Lung Cell Mol Physiol 2008; 295: L698-L707
37. Bullard JE, Nogee LM, Heterozygosity for ABCA3 mutations modifi es the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation, Pediatr Res 2007; 62: 176-179.
38. Fitzgerald ML, Xavier R, Haley KJ, Welti R, Goss JL, Brown CE, Zhuang DZ, Bell SA, Lu N, McKee M, Seed B, Freeman MW, ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol. J Lipid Res 2007; 48: 621-632.
39. Cheong N, Zhang H, Madesh M, Zhao M, Yu K, Dodia C, Fisher AB, Savani RC, Shuman H, ABCA3 is critical for lamellar body biogenesis in vivo, J Biol Chem 2007; 282: 23811-23817.
40. Besnard V, Wert SE, Stahlman MT, Postle AD, Xu Y, Ikegami M, Whitsett JA, Deletion of Scap in alveolar type II cells infl uences lung lipid homeostasis and identifi es a compensatory role for pulmonary lipofi broblasts, J Biol Chem 2009; 284: 4018-4030.
41. Besnard V, Xu Y, Whitsett JA, Sterol response element binding protein and thyroid transcription factor-1 (Nkx2.1) regulate Abca3 gene expression, Am J Physiol Lung Cell Mol Physiol 2007; 293: L1395-L1405
42. Matsuzaki Y, Besnard V, Clark JC, Xu Y, Wert SE, Ikegami M, Whitsett JA, STAT3 regulates ABCA3 expression and infl uences lamellar body formation in alveolar type II cells, Am J Respir Cell Mol Biol 2008; 38: 551-558.
43. Wang Y, Kuan PJ, Xing C, Cronkhite JT, Torres F, Rosenblatt RL, DiMaio JM, Kinch LN, Grishin NV, Garcia CK, Genetic defects in surfactant protein A2 are associated with pulmonary fi brosis and lung cancer, Am J Hum Genet 2009; 84: 52-59.
44. Deterding RR, Pye C, Fan LL, Langston C, Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia, Pediatr Pulmonol 2005; 40: 157-165.
45. Deutsch GH, Young LR, Deterding RR, Fan LL, Dell SD, Bean JA, Brody AS, Nogee LM, Trapnell BC, Langston C; Pathology Cooperative Group, Albright EA, Askin FB, Baker P, Chou PM, Cool CM, Coventry SC, Cutz E, Davis MM, Dishop MK, Galambos C, Patterson K, Travis WD, Wert SE, White FV; ChILD Research Co-operative, Diffuse lung disease in young children: application of a novel classifi cation scheme, Am J Respir Crit Care Med 2007; 176: 1120-1128.
46. Davies SJ, Gosney JR, Hansell DM, Wells AU, du Bois RM, Burke MM, Sheppard MN, Nicholson AG, Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease, Thorax 2007; 62: 248-252.
47. Coletta EN, Voss LR, Lima MS, Arakaki JS, Câmara J, D'Andretta Neto C, Pereira CA, Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia accompanied by airfl ow obstruction, J Bras Pneumol 2009; 35: 489-494.
48. Stahlman MT, Gray ME, Immunogold EM localization of neurochemicals in human pulmonary neuroendocrine cells, Microsc Res Tech 1997; 37: 77-91.
49. Reynolds SD, Giangreco A, Power JH, Stripp BR, Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration, Am J Pathol 2000; 156: 269-278.
50. Giangreco A, Reynolds SD, Stripp BR, Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction, Am J Pathol 2002; 161: 173-182
51. Neptune ER, Podowski M, Calvi C, Cho JH, Garcia JG, Tuder R, Linnoila RI, Tsai MJ, Dietz HC, Targeted disruption of NeuroD, a proneural basic helix-loop-helix factor, impairs distal lung formation and neuroendocrine morphology in the neonatal lung, J Biol Chem 2008; 283: 21160-21169